Drug Could Be Promising New Option Against Eczema
FRIDAY, May 21, 2021 (HealthDay News) — A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition — eczema. In two phase 3 clinical trials, patients with moderate to severe eczema showed rapid and significant improvements after taking the drug, said researchers atContinue Reading